Du är här

2014-05-09

Biotie: Change in the number of votes

tock Exchange Release 9
May 2014 at 09.05 am

Biotie: Change in the number of votes

Biotie Therapies Corp. ("Biotie" or the "Company") has conveyed Biotie shares
held as treasury shares pursuant to the Stock Option Plan 2011 and the Equity
Incentive Plan 2011 as follows:

--------------------------------------------------------------------------------------------------
|Shares conveyed Cumulative shares conveyed since 2 January 2014 Remaining shares to be conveyed |
|155,000 1,246,250 2,075,410 |
| |
--------------------------------------------------------------------------------------------------
Under the Stock Option Plan 2011, the owners of the stock options may
subscribe for a maximum total of 7,401,000 new shares in the Company or
existing shares held by the Company. A total of 155,000 shares have been
subscribed for during the period 4 April 2014 and 8 May 2014 and 155,000 of
the treasury shares will be used for these share subscriptions. The
subscription price of EUR 0.01 per share has been fully paid by the employee
and the EUR 1,550 funds received will be credited to the Company's reserve
for non-restricted equity.

Based on the Equity Incentive Plan 2011 no shares have been conveyed during
the period 4 April 2014 and 8 May 2014.

The conveyed shares previously held as treasury shares have not carried any
voting rights. The conveyance does not affect the number of registered
shares. After the conveyances the changes are as follows:

-----------------------------------------------------------------------------------------------
|Increase in number of outstanding shares Total amount of Number of the Total number |
| |
| |
| voting rights Company's shares held of registered |
| |
| |
| by the Group shares |
|155,000 447,520,899 8,511,499 456,032,398 |
| |
-----------------------------------------------------------------------------------------------
Turku, 9 May 2014

Biotie Therapies Corp.
Timo Veromaa, President and CEO

For further information, please contact:
Virve Nurmi, Investor Relations Manager, Biotie Therapies Corp.
tel. +358 2 274 8900, e-mail:virve.nurmi@biotie.com

www.biotie.com
DISTRIBUTION:
NASDAQ OMX Helsinki Ltd
Main Media

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Biotie Therapies Oyj via Globenewswire

HUG#1783876

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.